europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Library
Become a member
✕

MetGen receives John Sime Award and Plantics becomes PitchFest winner at #EFIB2018

30/10/2017
PRESS RELEASE
IB1

MetGen receives John Sime Award and Plantics becomes PitchFest winner at #EFIB2018

Wealth of innovation on display at annual showcase event demonstrates Europe’s strong response to SDG challenges and potential of the circular bioeconomy.

Brussels, 30 October 2018 – Recognised by their peers for their innovative bio-based solutions at the 11th Annual Forum for Industrial Biotechnology and the Bioeconomy (EFIB), Finland’s MetGen Oy received the coveted annual John Sime Award and Plantics BV from the Netherlands won the strongly contested PitchFest.

The John Sime Award for the best innovation presentation was received by Matti Heikkilä, CTO of Finnish company MetGen Oy from EuropaBio’s Secretary General, Joanna Dupont-Inglis and Toulouse White Biotechnology’s Founding Director, Pierre Monsan in recognition of their pioneering work in designing enzymatic processes and solutions for industrial biorefineries. “We are honoured to be this year’s John Sime Award recipients,” says Heikkilä. “MetGen has collaboration written in our DNA: We always tailor the enzymatic solutions and licensed technologies to match the customer specific need. The winning technologies presented at EFIB are designed to solve value-chain-wide challenges, and they are developed in the spirit of open innovation. While the biggest thanks belong to MetGen’s team for coming up with these incredible technologies, we also owe a debt of deep gratitude to all the European collaboration partners who have shared our audacious visions and worked with us towards shared objectives. We believe, the only thing that a bioindustry revolution needs is more collaboration.”

With its strong, 100% plant-based and fully biodegradable bioplastic, Plantics BV was voted PitchFest winner by the participants, in the face of strong competition from 4 other pitching companies: “We are delighted to emerge as winners,” says CEO Dr. Wridzer Bakker. “We believe our Plantics-GX technology can become a building block for the bioeconomy, having reached the position where our biopolymer based on plants can provide an environmentally sustainable alternative for several applications at a competitive prize.”

Agnes Borg, Industrial Biotech Director at EuropaBio commented: “EFIB remains a key forum showcasing leading innovation in industrial biotechnology and the bioeconomy, and providing answers to key challenges. We are delighted to congratulate both MetGen and Plantics on their awards and would also thank all the attendees, who together demonstrated that the drive towards building a circular bioeconomy in Europe is gathering real momentum.”

MetGen receives John Sime Award and Plantics becomes PitchFest winner at #EFIB2018


Download
Share
Alexandra Simionca
Alexandra Simionca

Related posts

17/01/2023

EuropaBio launches SME BioForum in Rare Diseases


Read more
17/01/2023

EuropaBio launches Industry Advisory Group for new Biomanufacturing Platform


Read more
16/01/2023

SwiftPharma joins EuropaBio: pioneering sustainable, scalable and affordable plant-made therapeutic proteins


Read more
19/12/2022

EuropaBio sat down with new member Association of Biotechnological Companies Bioforum, to find out how they champion biotech in central and eastern Europe


Read more

Important links

  • EuropaBio launches SME BioForum in Rare Diseases
  • EuropaBio launches Industry Advisory Group for new Biomanufacturing Platform

Categories in our Newsroom

Search by tags

  • Innovation
  • Excellence
  • Science
  • ATMPs
  • Healthcare Biotech
  • Industrial Biotech
  • Investment
  • EuropaBio
  • EFIB
  • Regulation
  • Rare Diseases
  • COVID-19
  • Members
  • Cancer
  • Patients
  • Patient BioForum
  • Gene & Cell Therapies
  • Accessibility
  • Intellectual Property
  • Pharmaceutical Strategy for Europe

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies